Abstract
Nanoparticles of several organic and inorganic materials are nowadays under investigation for many diverse technologies. Amorphous silicon dioxide, also known as silica, is a versatile material for nanostructure preparation. Silica nanoparticles with different structure or surface chemistry have been prepared for biomedical applications. Size, shape and functionalization rule nanoparticle interaction with cells and tissues finally regulating the potential toxic effects. “Ad hoc” surface chemical moieties and specific physical features of their structure increase silica nanoparticle biocompatibility suggesting their possible future employment for gene or drug delivery.
Keywords: Nanoparticles, silica, drug delivery, biocompatibility, toxicity, nanomedicine
Drug Delivery Letters
Title: SiO2 NPs: Promising Candidates for Drug and Gene Delivery
Volume: 1 Issue: 1
Author(s): Giuseppe Bardi
Affiliation:
Keywords: Nanoparticles, silica, drug delivery, biocompatibility, toxicity, nanomedicine
Abstract: Nanoparticles of several organic and inorganic materials are nowadays under investigation for many diverse technologies. Amorphous silicon dioxide, also known as silica, is a versatile material for nanostructure preparation. Silica nanoparticles with different structure or surface chemistry have been prepared for biomedical applications. Size, shape and functionalization rule nanoparticle interaction with cells and tissues finally regulating the potential toxic effects. “Ad hoc” surface chemical moieties and specific physical features of their structure increase silica nanoparticle biocompatibility suggesting their possible future employment for gene or drug delivery.
Export Options
About this article
Cite this article as:
Bardi Giuseppe, SiO2 NPs: Promising Candidates for Drug and Gene Delivery, Drug Delivery Letters 2011; 1 (1) . https://dx.doi.org/10.2174/2210304x11101010009
DOI https://dx.doi.org/10.2174/2210304x11101010009 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo
Clinical Cancer Drugs New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry Synthesis, Crystal Structure, Characterization and DNA Binding Studies of Novel Copper (II) Complex Based on Amino Acid Schiff Base
Current Organic Chemistry Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
Current Pharmaceutical Biotechnology Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition The Role of Components of the Lymphoreticular System in Transmissible Spongiform Encephalopathy Pathogenesis and Neuroinvasion
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Potential of Statins for Individualized Colorectal Cancer Chemoprevention
Current Drug Targets RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)
Anti-Cancer Agents in Medicinal Chemistry Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2
Current Neurovascular Research Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
Current Neuropharmacology Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Recent Patents on Anti-Cancer Drug Discovery Differential Regulation of Neurotoxin in HIV Clades: Role of Cocaine and Methamphetamine
Current HIV Research Cancer Stem Cells and the Biology of Brain Tumors
Current Stem Cell Research & Therapy Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications
Current Medicinal Chemistry Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis
Current Signal Transduction Therapy Metal Based Frameworks for Drug Delivery Systems
Current Topics in Medicinal Chemistry Synthesis of Some Coumarinyl Chalcones and their Antiproliferative Activity Against Breast Cancer Cell Lines
Letters in Drug Design & Discovery Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities
Anti-Cancer Agents in Medicinal Chemistry